#targeted therapy — Monday, June 01, 2026 (2 items)
| 0 | ℹ |
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.
(nature.com)
|
Nature Medicine 2026-06-01 | #cancer #targeted therapy #gist #fgfr #sdh | |
| 0 | ℹ |
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.
(nature.com)
|
Nature Medicine 2026-06-01 | #cancer #clinical trial #amplification #targeted therapy |